Sierra Isabel, Pérez-Mayoral Julyann, Rosado Kathia, Maldonado Valerie, Alicea-Zambrana Kimberly, Reyes José S, Torres Marla, Tous Luis, Lopéz-Acevedo Nicolas, Diaz-Algorrí Yaritza, Carlo-Chevere Victor, Rodriguez-Quilichini Segundo, Cruz-Correa Marcia
Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Hato Rey Pathology Laboratories, San Juan, Puerto Rico.
J Racial Ethn Health Disparities. 2021 Oct;8(5):1185-1191. doi: 10.1007/s40615-020-00876-7. Epub 2020 Oct 2.
Colorectal cancer is the leading cause of cancer death in Puerto Rico and third among Hispanics in the USA. Up to 2-4% of colorectal cancer cases are a result of Lynch syndrome (LS), a hereditary cancer syndrome caused by a germline mutation in at least one of the DNA mismatch repair genes. The objective of this study was to determine the prevalence of LS in colorectal tumors during the first 15-months after the implementation of universal tumor-based screening for LS in Puerto Rico.
A total of 317 colorectal tumors were evaluated in a large private pathology laboratory from September 2014 to December 2015. Clinical characteristics were obtained from the pathology reports. Unadjusted and adjusted logistic regression models were used to estimate the magnitude of association (odds ratio [OR] with 95% confidence intervals [CI]) between absent MMR protein expression and patient characteristics.
Most cases (93.4%) were analyzed by immunohistochemistry; 11.8% (35 of 296) had deficient mismatch repair protein expression. While 29 of the 317 cases were subjected to PCR-based microsatellite instability analysis of which 10.3% (3 of 317) had microsatellite instability. In total, 11.0% of the tumors were reported MMR deficient. These tumors were more likely from females and more likely localized in the proximal colon compared to those with proficient MMR expression.
Our data is consistent with the results from other studies including US Hispanics, where approximately 10% of Hispanic individuals with colorectal cancer have microsatellite instability. Our results support universal tumor-based screening for LS among Hispanics in accordance with National Comprehensive Cancer Network guidelines.
结直肠癌是波多黎各癌症死亡的主要原因,在美国西班牙裔中位列第三。高达2%-4%的结直肠癌病例是林奇综合征(LS)所致,这是一种由至少一个DNA错配修复基因的种系突变引起的遗传性癌症综合征。本研究的目的是确定在波多黎各实施基于肿瘤的LS通用筛查后的前15个月内,结直肠肿瘤中LS的患病率。
2014年9月至2015年12月期间,一家大型私立病理实验室对总共317例结直肠肿瘤进行了评估。临床特征从病理报告中获取。采用未调整和调整后的逻辑回归模型来估计错配修复蛋白表达缺失与患者特征之间的关联强度(优势比[OR]及95%置信区间[CI])。
大多数病例(93.4%)通过免疫组织化学进行分析;11.8%(296例中的35例)存在错配修复蛋白表达缺陷。在317例病例中,有29例进行了基于聚合酶链反应的微卫星不稳定性分析,其中10.3%(317例中的3例)存在微卫星不稳定性。总体而言,11.0%的肿瘤报告为错配修复缺陷。与错配修复蛋白表达正常的肿瘤相比,这些肿瘤更可能来自女性,且更可能位于近端结肠。
我们的数据与包括美国西班牙裔在内的其他研究结果一致,即大约10%的西班牙裔结直肠癌患者存在微卫星不稳定性。我们的结果支持根据美国国立综合癌症网络指南对西班牙裔进行基于肿瘤的LS通用筛查。